R1 RCM Inc. (NASDAQ:RCM) Shares Purchased by Bardin Hill Management Partners LP

Bardin Hill Management Partners LP boosted its holdings in shares of R1 RCM Inc. (NASDAQ:RCM) by 2.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 535,939 shares of the healthcare provider’s stock after purchasing an additional 10,728 shares during the period. R1 RCM comprises 3.5% of Bardin Hill Management Partners LP’s portfolio, making the stock its 10th biggest holding. Bardin Hill Management Partners LP owned about 0.13% of R1 RCM worth $7,594,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Glazer Capital LLC acquired a new position in shares of R1 RCM in the 3rd quarter worth approximately $135,678,000. Dimensional Fund Advisors LP raised its stake in R1 RCM by 4.5% during the second quarter. Dimensional Fund Advisors LP now owns 3,154,888 shares of the healthcare provider’s stock worth $39,624,000 after acquiring an additional 136,808 shares in the last quarter. Sea Cliff Partners Management LP lifted its holdings in shares of R1 RCM by 14.3% during the second quarter. Sea Cliff Partners Management LP now owns 2,437,450 shares of the healthcare provider’s stock valued at $30,614,000 after acquiring an additional 305,672 shares during the period. Empyrean Capital Partners LP acquired a new stake in shares of R1 RCM in the 2nd quarter valued at $26,376,000. Finally, Alpine Associates Management Inc. bought a new stake in shares of R1 RCM in the 3rd quarter worth about $25,680,000. 61.10% of the stock is owned by institutional investors and hedge funds.

R1 RCM Stock Performance

Shares of NASDAQ:RCM opened at $14.31 on Monday. The company has a current ratio of 1.79, a quick ratio of 1.79 and a debt-to-equity ratio of 0.76. R1 RCM Inc. has a 1-year low of $8.87 and a 1-year high of $15.12. The stock has a market capitalization of $6.04 billion, a P/E ratio of -95.39 and a beta of 0.84. The business has a 50-day moving average price of $14.25 and a two-hundred day moving average price of $13.54.

R1 RCM (NASDAQ:RCM) last posted its quarterly earnings results on Tuesday, November 5th. The healthcare provider reported ($0.05) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.04). R1 RCM had a negative return on equity of 2.18% and a negative net margin of 2.48%. The business had revenue of $656.80 million for the quarter, compared to the consensus estimate of $640.93 million. R1 RCM’s revenue for the quarter was up 14.7% compared to the same quarter last year. Equities analysts predict that R1 RCM Inc. will post -0.18 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages recently issued reports on RCM. Cantor Fitzgerald reissued a “neutral” rating and set a $14.30 price target on shares of R1 RCM in a report on Friday, October 4th. TD Cowen reiterated a “hold” rating and issued a $14.30 target price (down previously from $20.00) on shares of R1 RCM in a research note on Monday, August 5th. Morgan Stanley lowered R1 RCM from an “overweight” rating to an “equal weight” rating in a research report on Thursday, August 8th. Finally, Truist Financial cut their price objective on R1 RCM from $16.00 to $14.30 and set a “hold” rating for the company in a research report on Thursday, August 8th. Thirteen analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $15.41.

R1 RCM Company Profile

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.